Inhibition of the activation of nuclear factor kappa B to reduce myocardial reperfusion injury and infarct size.
Thiemermann
Christoph
C
D000818:Animals; D001549:Benzamides / Q000627:therapeutic use*; D006801:Humans; D020672:I-kappa B Proteins / Q000037:antagonists & inhibitors*; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000517:prevention & control*; D016328:NF-kappa B / Q000378:metabolism*; D010766:Phosphorylation
D001549:Benzamides; D020672:I-kappa B Proteins; D016328:NF-kappa B; C492919:N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide